Less Ads, More Data, More Tools Register for FREE

Faron Pharmaceuticals Recruits First Patient For Traumakine Trial

Tue, 29th Dec 2015 07:48

LONDON (Alliance News) - Biopharmaceutical company Faron Pharmaceuticals Oy on Tuesday said it has enrolled the first patient for the phase 3 clinical trial of Traumakine, its acute respiratory distress syndrome treatment.

Acute respiratory distress syndrome is a severe disease which has a mortality rate of 35% to 40% and for which there is currently no approved pharmalogical treatment, Faron said.

"We believe that Traumakine presents a significant opportunity for those suffering from ARDS, the hospitals which treat them and the societies covering the recovery of ARDS patients," said Faron Chief Executive Markku Jalkanen.

By Sam Unsted; samunsted@alliancenews.com; @SamUAtAlliance

Copyright 2015 Alliance News Limited. All Rights Reserved.

Related Shares

More News
4 Jun 2024 11:24

AIM WINNERS & LOSERS: Vast Resources touts progress across mines

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Tuesday.

20 May 2024 09:03

Faron Pharma celebrates positive read-out in ongoing MDS trial

(Alliance News) - Faron Pharmaceuticals Ltd on Monday noted a positive read-out regarding the ongoing Bexmab trial on myelodysplastic syndrome, a form...

3 May 2024 13:39

TRADING UPDATES: Kelso raises stake in NCC; Transense joins project

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and Tuesday and not separately reported by Allia...

30 Apr 2024 16:33

Faron Pharmaceuticals extends funding agreement with IPF

(Sharecast News) - Faron Pharmaceuticals announced on Tuesday that it has extended its agreement with lender IPF to ensure continued financial support...

15 Apr 2024 10:58

Faron Pharmaceuticals reappoints former finance chief on interim basis

(Alliance News) - Faron Pharmaceuticals Ltd on Monday said it appointed a new interim chief financial officer to replace the outgoing James O'Brien.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.